This is due to the higher frequency of MS among demyelinating CNS disorders compared to MOGAD (approximately 40-50 times higher), and the common tendency among physicians to routinely test MS patients for MOG-IgG in order to exclude other diagnostic possibilities. The gene discussed is MOG; the disease is myeloid sarcoma.